Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Formosa Ingredient Factory Tbk (BOBA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Formosa Ingredient Factory TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Formosa Ingredient Factory Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Formosa Ingredient Factory Tbk trades at Rp236 (market cap 286.63B, 1.05M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 576.7B, 3.09M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2× Formosa Ingredient Factory Tbk's market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.09M versus 1.05M). Which is the better fit depends on your goals.

BOBALABS
Market Cap
286.63B576.7B
Volume
1.05M3.09M
Lot
10.48K30.86K
Turnover
251.69M464.29M
Average Price
240.12150.47
Value
251.69M464.29M
Indicative Equilibrium Price
248147
Indicative Equilibrium Volume
300311

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BOBA
View details
LABS
View details

About Formosa Ingredient Factory Tbk

PT Formosa Ingredient Factory, Tbk ("Company") was established based on the Deed No. 04 dated April 11, 2016 of Besus Tri Prasetyo, S.H., Notary in Tangerang. The Company started its commercial operations since August 18, 2017.

Read more on BOBA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS